SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENTSecurities Purchase, Loan and Security Agreement • May 23rd, 2008 • Java Detour Inc. • Retail-food stores • California
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of May 19, 2008, by and among Java Detour, Inc. a Delaware corporation (the “Company”), on the one hand, and Java Finance, LLC, and Clydesdale Partners, LLC (“Clydesdale”), on the other hand (each a “Secured Party” and together the “Secured Parties”).
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENTSecurities Purchase, Loan and Security Agreement • July 17th, 2017 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of July 14, 2017, by and between Capstone Therapeutics Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”), and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New York 10168 (the “Buyer”).
SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENTSecurities Purchase, Loan and Security Agreement • March 26th, 2019
SECURITY AGREEMENT (the “Amendment”) is made as of the 15th day of March, 2019 by and between Capstone Therapeutics Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”), and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New York 10168 (the “Buyer”).
Second AMENDMENT TO SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENTSecurities Purchase, Loan and Security Agreement • March 19th, 2019 • Capstone Therapeutics Corp. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (the “Amendment”) is made as of the 15th day of March, 2019 by and between Capstone Therapeutics Corp., a Delaware corporation located at 1275 West Washington Street, Suite 104, Tempe, Arizona 85281 (the “Company”), and BP Peptides, LLC, a Delaware limited liability company located at 122 East 42nd Street, Suite 4305, New York, New York 10168 (the “Buyer”).
